Last reviewed · How we verify
Pravastatin and Cyclosporine — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Pravastatin and Cyclosporine (Pravastatin and Cyclosporine) — University of California, San Francisco.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Pravastatin and Cyclosporine TARGET | Pravastatin and Cyclosporine | University of California, San Francisco | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Pravastatin and Cyclosporine CI watch — RSS
- Pravastatin and Cyclosporine CI watch — Atom
- Pravastatin and Cyclosporine CI watch — JSON
- Pravastatin and Cyclosporine alone — RSS
Cite this brief
Drug Landscape (2026). Pravastatin and Cyclosporine — Competitive Intelligence Brief. https://druglandscape.com/ci/pravastatin-and-cyclosporine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab